Eiger BioPharmaceuticals, Inc. - Common Stock (NQ:EIGR)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 10, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eiger BioPharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Notifies Eiger BioPharmaceuticals, Inc. (EIGR) Investors of Class Action and Encourages Investors to Actively Participate

November 16, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Eiger BioPharmaceuticals, Inc. (EIGR) on Behalf of Investors

November 16, 2022

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Eiger BioPharmaceuticals, Inc. (EIGR) on Behalf of Investors

November 15, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

Eiger BioPharma Shuns Plans For FDA Emergency Use Nod For COVID-19 Treatment ↗

October 05, 2022

Via Benzinga

FDA Might Need New Data From Eiger Bio's COVID-19 Treatment Prospect ↗

September 06, 2022

Via Benzinga

EMA's Advisory Committee Recommends Eiger's Zokinvy In Premature Aging Disorder ↗

May 20, 2022

Via Benzinga

EIGER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm

November 14, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

ROSEN, A TOP RANKED FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR

November 13, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Eiger Biopharmaceutials, Inc. (EIGR)

November 09, 2022

From Robbins LLP

Via Business Wire

NASDAQ:EIGR Investor Notice Investigation Announced over Potential Wrongdoing at Eiger BioPharmaceuticals, Inc. ↗

November 09, 2022

San Diego, CA -- (SBWIRE) -- 11/09/2022 -- Certain directors of Eiger BioPharmaceuticals, Inc are under investigation over potential breaches of fiduciary duties.

Via SBWire

EQUITY ALERT: Rosen Law Firm Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR

November 09, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

November 09, 2022

From The Schall Law Firm

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

November 08, 2022

From The Schall Law Firm

Via Business Wire

11 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 05, 2022

Gainers Bionano Genomics (NASDAQ:BNGO) stock increased by 9.8% to $2.24. The company's market cap stands at $649.9 million.

Via Benzinga

NASDAQ:EIGR Investor Notice: Investigation over Possible Securities Laws Violations by Eiger BioPharmaceuticals, Inc. ↗

September 21, 2022

San Diego, CA -- (SBWIRE) -- 09/21/2022 -- Eiger BioPharmaceuticals, Inc is under investigation concerning potential securities laws violations in connection with certain financial statements.

Via SBWire

Starbucks To $94? Here Are 5 Other Price Target Changes For Wednesday ↗

September 07, 2022

Citigroup raised the price target on Starbucks Corporation (NASDAQ: SBUX) from $90 to $94. Citigroup analyst Jon Tower maintained a Neutral rating on the stock. Starbucks shares fell 0.1% to $84.50 in...

Via Benzinga

Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday ↗

September 07, 2022

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.

Via Benzinga

Dow Tumbles Over 200 Points; ChannelAdvisor Shares Spike Higher ↗

September 06, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 06, 2022

Via Benzinga

Nasdaq Drops 100 Points; DWAC Shares Plummet ↗

September 06, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq dropping over 100 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around...

Via Benzinga

Bed Bath & Beyond, Eiger BioPharmaceuticals And Some Other Big Stocks Moving Lower On Tuesday ↗

September 06, 2022

Via Benzinga

Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session ↗

September 06, 2022

Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist...

Via Benzinga

US Stocks Trade Lower; Dow Drops Over 100 points ↗

September 06, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around 3%,...

Via Benzinga

Eiger BioPharmaceuticals Earnings Perspective: Return On Capital Employed ↗

August 24, 2022

According to Benzinga Pro data, during Q2, Eiger BioPharmaceuticals (NASDAQ:EIGR) posted sales of $4.09 million. Earnings were up 3.35%, but Eiger BioPharmaceuticals still reported an overall loss of...

Via Benzinga

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate ↗

August 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Recap of Wednesday's Biotech Catalysts - End of The Day Summary ↗

July 20, 2022

Via Benzinga

The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data ↗

June 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine ↗

May 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

64 Biggest Movers From Yesterday ↗

March 18, 2022

Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:...

Via Benzinga

31 Stocks Moving In Thursday's Mid-Day Session ↗

March 17, 2022

Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 83.2% to $0.4348 after the company reported FY21 results. Allego N.V. (NASDAQ: ALLG) shares gained 45.5% to $9.40. Spartan...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.